Point-of-Care Lung Ultrasound Feasible for Pneumonia Diagnosis in Primary Care
THURSDAY, May 26, 2022 (HealthDay News) — Point-of-care lung ultrasound in primary care is feasible and useful for investigating suspected community-acquired pneumonia (CAP), according to a study published in the May issue of Annals of Family Medicin…
Learn MoreBreastfeeding Duration Has Modest Effect on Child’s Cognition
THURSDAY, May 26, 2022 (HealthDay News) — Associations between breastfeeding duration and cognitive scores persist after adjusting for socioeconomic factors and maternal cognitive ability, although the effect is modest, according to a study published…
Learn MorePost-COVID Conditions Are Common Among Adult Survivors
WEDNESDAY, May 25, 2022 (HealthDay News) — Incident conditions that may be attributable to COVID-19 are common among adult COVID-19 survivors, according to research published in the May 24 early-release issue of the U.S. Centers for Disease Control …
Learn MoreAbbott to Re-Open Baby Formula Plant on June 4
WEDNESDAY, May 25, 2022 (HealthDay News) — Beginning June 4, Abbott Nutrition will restart producing baby formula at a shuttered factory that has been central to the ongoing shortage of infant formula in the United States, the company announced on Tu…
Learn MoreFDA Approves First Treatment for Eosinophilic Esophagitis
WEDNESDAY, May 25, 2022 (HealthDay News) — The U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Dupixent (dupilumab) to treat eosinophilic esophagitis patients 12 years and older.The efficacy and safety of Dupixent was evaluat…
Learn MoreSuicide by Firearm Down Globally From 1990 to 2019
WEDNESDAY, May 25, 2022 (HealthDay News) — Most of the world saw a trend of decreasing suicide by firearm between 1990 and 2019, according to a study published online May 25 in PLOS ONE.Irena Ilic, M.D., Ph.D., from the University of Belgrade in Serb…
Learn MoreAmerican Urological Association, May 13-16
The annual meeting of the American Urological Association was held from May 13 to 16 in New Orleans and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in urology. T…
Learn MoreGout Drug May Cut Mortality in Heart Failure Hospitalizations
WEDNESDAY, May 25, 2022 (HealthDay News) — Among patients with an acute heart failure exacerbation, treatment with colchicine for a gout flare is associated with significantly lower in-hospital mortality, according to a study published online April 2…
Learn MoreImpact of Policy Changes for Anemia Care in Hemodialysis Examined
WEDNESDAY, May 25, 2022 (HealthDay News) — Recommended erythropoietin-stimulating agent dosing changes for anemia care in adults undergoing hemodialysis led to lower erythropoietin-stimulating agent use and lower hemoglobin levels, according to a study published online May 19 in the Clinical Journal of the American Society of Nephrology.
Haesuk Park, Ph.D., from the University of Florida in Gainesville, and colleagues examined anemia care and clinical outcomes before and after the U.S. Centers for Medicare & Medicaid Services bundled payment and the revised U.S. Food and Drug Administration-recommended erythropoietin-stimulating agent labeling for adults receiving hemodialysis. Clinical outcomes, including major adverse cardiovascular events, cardiovascular mortality, and heart failure, were compared before (2006 to 2010) and after (2012 to 2016) policy implementation.
The researchers found that among the 481,564 patients, there was an immediate decrease in erythropoietin-stimulating agent use by 84.8 per 1,000 persons, with a significant decrease in the slope of the trend line. A rapid increase was seen in use of blood transfusion by 8.34 per 1,000 persons in April 2012, which then decreased gradually. From January 2006 to December 2016, there was a decrease observed in the percentage of patients with hemoglobin >11 g/dL from 68 to 28 percent, whereas an increase from 5 to 9 percent was seen in those with hemoglobin
“Due to these significant changes in clinical outcomes, longitudinal follow-up is warranted to assess if the policy changes warrant further refinement,” Park said in a statement.
Several authors disclosed financial ties to the pharmaceutical and biopharmaceutical industries.
Learn MoreAlzheimer Disease in Down Syndrome Similar to Autosomal Dominant Form
WEDNESDAY, May 25, 2022 (HealthDay News) — Variability of age at symptom onset for Alzheimer disease with Down syndrome is similar to autosomal-dominant Alzheimer disease, while mortality data are compatible with fully penetrant Alzheimer disease, ac…
Learn More